Novel Imbricatolic acid derivatives as protein tyrosine phosphatase-1B inhibitors: Design, synthesis, biological evaluation and molecular docking

Bioorganic & Medicinal Chemistry Letters
2016.0

Abstract

Protein tyrosine phosphatase (PTP-1B) antagonizes insulin signaling and is a potential therapeutic target for insulin resistance associated with obesity and type 2 diabetes. To find potential PTP-1B inhibitors, derivatives of Imbricatolic acid (1) have been synthesized by introducing various nitrogenous functionalities at C-15 and C-19 positions. They were evaluated for PTP-1B enzyme inhibition activity. Compounds 3, 6, 14, and 15 exhibited promising PTP-1B inhibitory activity at 10 μM concentrations with IC50 6.3, 6.8, 7.0 and 7.8 values, respectively. Structure activity relationship and molecular docking studies of these derivatives demonstrated that the integrity of the polar substituents were important for significant PTP-1B inhibitory activity. The Imbricatolic acid and active derivatives in this study might represent a starting point for development of new potential PTP-1B inhibitors.

Knowledge Graph

Similar Paper

Novel Imbricatolic acid derivatives as protein tyrosine phosphatase-1B inhibitors: Design, synthesis, biological evaluation and molecular docking
Bioorganic & Medicinal Chemistry Letters 2016.0
Design, synthesis and docking studies on phenoxy-3-piperazin-1-yl-propan-2-ol derivatives as protein tyrosine phosphatase 1B inhibitors
Bioorganic & Medicinal Chemistry Letters 2010.0
Synthesis of protein tyrosine phosphatase 1B inhibitors: Model validation and docking studies
Bioorganic & Medicinal Chemistry Letters 2009.0
Identification of novel urea derivatives as PTP1B inhibitors: synthesis, biological evaluation and structure–activity relationships
MedChemComm 2013.0
Synthesis and biological evaluation of oleanolic acid derivatives as PTP1B inhibitors
European Journal of Medicinal Chemistry 2013.0
Design, synthesis and biological evaluation of novel arylidine-malononitrile derivatives as non-carboxylic inhibitors of protein tyrosine phosphatase 1B
Medicinal Chemistry Research 2013.0
Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity
Bioorganic & Medicinal Chemistry 2009.0
Discovery of novel and potent heterocyclic carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors
Bioorganic & Medicinal Chemistry Letters 2012.0
Synthesis, in vitro and in silico screening of ethyl 2-(6-substituted benzo[d]thiazol-2-ylamino)-2-oxoacetates as protein-tyrosine phosphatase 1B inhibitors
European Journal of Medicinal Chemistry 2012.0
Canthinone alkaloids are novel protein tyrosine phosphatase 1B inhibitors
Bioorganic & Medicinal Chemistry Letters 2015.0